223 related articles for article (PubMed ID: 35888123)
21. The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment options.
Younossi Z; Stepanova M; Sanyal AJ; Harrison SA; Ratziu V; Abdelmalek MF; Diehl AM; Caldwell S; Shiffman ML; Schall RA; McColgan B; Subramanian GM; Myers RP; Muir A; Afdhal NH; Bosch J; Goodman Z
J Hepatol; 2018 Dec; 69(6):1365-1370. PubMed ID: 30144554
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: the PRECORIS study.
Calvet D; Touzé E; Varenne O; Sablayrolles JL; Weber S; Mas JL
Circulation; 2010 Apr; 121(14):1623-9. PubMed ID: 20351236
[TBL] [Abstract][Full Text] [Related]
23. Atherosclerosis in chronic hepatitis C virus patients with and without liver cirrhosis.
Barakat AAE; Nasr FM; Metwaly AA; Morsy S; Eldamarawy M
Egypt Heart J; 2017 Jun; 69(2):139-147. PubMed ID: 29622968
[TBL] [Abstract][Full Text] [Related]
24. CAD-LT score effectively predicts risk of significant coronary artery disease in liver transplant candidates.
Rachwan RJ; Kutkut I; Timsina LR; Bou Chaaya RG; El-Am EA; Sabra M; Mshelbwala FS; Rahal MA; Lacerda MA; Kubal CA; Fridell JA; Ghabril MS; Bourdillon PD; Mangus RS
J Hepatol; 2021 Jul; 75(1):142-149. PubMed ID: 33476745
[TBL] [Abstract][Full Text] [Related]
25. Utilization of aspirin and statin in management of coronary artery disease in patients with cirrhosis undergoing liver transplant evaluation.
Patel SS; Guzman LA; Lin FP; Pence T; Reichman T; John B; Celi FS; Liptrap E; Bhati C; Siddiqui MS
Liver Transpl; 2018 Jul; 24(7):872-880. PubMed ID: 29624871
[TBL] [Abstract][Full Text] [Related]
26. Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.
Duseja A; Singh SP; Saraswat VA; Acharya SK; Chawla YK; Chowdhury S; Dhiman RK; Jayakumar RV; Madan K; Misra SP; Mishra H; Modi SK; Muruganathan A; Saboo B; Sahay R; Upadhyay R
J Clin Exp Hepatol; 2015 Mar; 5(1):51-68. PubMed ID: 25941433
[TBL] [Abstract][Full Text] [Related]
27. Liver transplantation and non-alcoholic fatty liver disease.
Zezos P; Renner EL
World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
[TBL] [Abstract][Full Text] [Related]
28. Temporal trends in the utilization and outcomes of percutaneous coronary interventions in patients with liver cirrhosis.
Alqahtani F; Balla S; AlHajji M; Chaudhary F; Albeiruti R; Kawsara A; Alkhouli M
Catheter Cardiovasc Interv; 2020 Oct; 96(4):802-810. PubMed ID: 31713989
[TBL] [Abstract][Full Text] [Related]
29. Non-alcoholic fatty liver disease and cardiovascular risk.
Patil R; Sood GK
World J Gastrointest Pathophysiol; 2017 May; 8(2):51-58. PubMed ID: 28573067
[TBL] [Abstract][Full Text] [Related]
30. Combined liver transplantation and off-pump coronary artery bypass grafting: a report of two cases.
Uludag Yanaral T; Ertugrul G; Ulukan MO; Karaaslan P; Karaca IO; Dayangac M
Acta Chir Belg; 2022 Aug; 122(4):269-274. PubMed ID: 33251981
[TBL] [Abstract][Full Text] [Related]
31. Non-alcoholic fatty liver disease and liver transplantation.
Khan RS; Newsome PN
Metabolism; 2016 Aug; 65(8):1208-23. PubMed ID: 26997540
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.
Maliakkal BJ
Transl Gastroenterol Hepatol; 2020; 5():36. PubMed ID: 32632387
[TBL] [Abstract][Full Text] [Related]
33. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
34. Trends in Characteristics, Mortality, and Other Outcomes of Patients With Newly Diagnosed Cirrhosis.
Orman ES; Roberts A; Ghabril M; Nephew L; Desai AP; Patidar K; Chalasani N
JAMA Netw Open; 2019 Jun; 2(6):e196412. PubMed ID: 31251379
[TBL] [Abstract][Full Text] [Related]
35. Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis.
Sao R; Aronow WS
Arch Med Sci; 2018 Oct; 14(6):1233-1244. PubMed ID: 30393477
[TBL] [Abstract][Full Text] [Related]
36. Coronary artery bypass graft combined with liver transplantation in patients with advanced alcoholic liver cirrhosis: A case report.
Chai J; Wang K; Kong X; Pan C; Jiang W; Zhou W; Chen H; Xue F; Zhang L; Shen Z
Exp Ther Med; 2020 May; 19(5):3197-3202. PubMed ID: 32266015
[TBL] [Abstract][Full Text] [Related]
37. Severity of coronary artery disease is associated with non-alcoholic fatty liver dis-ease: A single-blinded prospective mono-center study.
Friedrich-Rust M; Schoelzel F; Maier S; Seeger F; Rey J; Fichtlscherer S; Herrmann E; Zeuzem S; Bojunga J
PLoS One; 2017; 12(10):e0186720. PubMed ID: 29073252
[TBL] [Abstract][Full Text] [Related]
38. Multi-detector computed tomography angiography for coronary artery disease: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(5):1-57. PubMed ID: 23074474
[TBL] [Abstract][Full Text] [Related]
39. Presence of alcoholic steatohepatitis, but no selective histological feature, indicates an increased risk of cirrhosis and premature death.
Semb S; Neermark S; Dam-Larsen S; Franzmann MB; Albrectsen J; Kallemose T; Becker U; Bendtsen F
Scand J Gastroenterol; 2016 Nov; 51(11):1367-74. PubMed ID: 27381376
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease.
Patel S; Kiefer TL; Ahmed A; Ali ZA; Tremmel JA; Lee DP; Yeung AC; Fearon WF
Am J Cardiol; 2011 Dec; 108(11):1552-5. PubMed ID: 21890080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
